NRP1 and familial pancreatic carcinoma: In pancreatic cancer, NRP1 is negatively regulated by miR-141, a member of the miR-200 family, and the miR-141/NRP1 axis represents a potentially valuable diagnostic and therapeutic target for this tumor [47].